BlackRock Inc. - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206. A total of 10 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,087
+8.8%
42,199
-0.0%
0.00%
Q2 2023$18,454
-38.5%
42,2200.0%0.00%
Q1 2023$29,989
-1.0%
42,2200.0%0.00%
Q4 2022$30,293
+236.6%
42,220
+5871.7%
0.00%
Q3 2022$9,0007070.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 32,270$150.00%
UBS Group AG 142$680.00%
BANK OF AMERICA CORP /DE/ 8$40.00%
WELLS FARGO & COMPANY/MN 188$890.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 138,672$66,0330.00%
STATE STREET CORP 22,678$10,7950.00%
MORGAN STANLEY 2$10.00%
COMERICA BANK 22$100.00%
BlackRock Inc. 42,199$20,0870.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders